Short- and Long-term Effects of Dialysate Calcium Concentrations on Mineral and Bone Metabolism in Hemodialysis Patients: The K4 Study

被引:7
作者
Sakoh, Teppei [1 ]
Taniguchi, Masatomo [2 ]
Yamada, Shunsuke [3 ]
Ohnaka, Shotaro [4 ]
Arase, Hokuto [3 ]
Tokumoto, Masanori [5 ]
Yanagida, Taihei [4 ]
Mitsuiki, Koji [1 ]
Hirakata, Hideki [1 ,2 ]
Nakano, Toshiaki [3 ]
Kitazono, Takanari [3 ]
Tsuruya, Kazuhiko [3 ,6 ,7 ]
机构
[1] Japanese Red Cross Fukuoka Hosp, Div Nephrol, Fukuoka, Japan
[2] Fukuoka Renal Clin, Fukuoka, Japan
[3] Kyushu Univ, Grad Sch Med Sci, Dept Med & Clin Sci, Fukuoka, Japan
[4] Steel Mem Yawata Hosp, Div Nephrol, Fukuoka, Japan
[5] Fukuoka Dent Coll, Dept Internal Med, Fukuoka, Japan
[6] Kyushu Univ, Grad Sch Med Sci, Dept Integrated Therapy Chron Kidney Dis, Fukuoka, Japan
[7] Nara Med Univ, Dept Nephrol, Nara, Japan
关键词
Calcium; dialysate calcium concentration; hemodialysis; parathyroid hormone;
D O I
10.1016/j.xkme.2019.08.002
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Rationale & Objective: The short- and long-term impact of conversion of dialysate calcium concentration from either 2.5 or 3.0 mEq/L to 2.75 mEq/L on mineral and bone metabolism remains unknown in hemodialysis patients. Study Design: Nonrandomized intervention study. Setting & Population: 12 hemodialysis patients treated at baseline with a 2.5-mEq/L dialysate calcium concentration and another 12 hemodialysis patients treated with a 3.0-mEq/L dialysate calcium concentration. Intervention: Use of 2.75-mEq/L dialysate calcium concentration. Outcomes: Changes in intradialytic calcium and phosphate clearance and changes in predialysis and intradialytic serum and ionized mineral and biochemical parameters over the 24 weeks following dialysate calcium conversion. Results: Conversion of dialysate calcium concentration from 2.5 to 2.75 mEq/L increased intradialytic calcium loading and serum total and ionized calcium levels, whereas conversion of dialysate calcium from 3.0 to 2.75 mEq/L decreased intradialytic calcium loading and serum total and ionized calcium levels. Dialysate calcium concentration conversion did not affect intradialytic serum parathyroid hormone level, intradialytic phosphate elimination, or predialysis serum calcium, phosphate, parathyroid hormone, and fibroblast growth factor 23 levels. Intradialytic calcium influx was determined by dialysate calcium concentration and predialysis serum calcium levels, whereas intradialytic phosphate elimination was determined by predialysis serum phosphate levels. Limitations: Small sample size and no control groups treated with 2.5- and 3.0-mEq/L dialysate calcium concentrations during the 24 weeks of the observation period. Conclusions: Conversion of dialysate calcium concentration from either 3.0 or 2.5 to 2.75 mEq/L results in expected changes in calcium loading based on predialysis calcium concentration. The dialysate calcium concentration should be personalized based on clinical factors.
引用
收藏
页码:296 / 306
页数:11
相关论文
共 48 条
  • [21] Impact of Long-Term Cinacalcet, Ibandronate or Teriparatide Therapy on Bone Mineral Density of Hemodialysis Patients: A Pilot Study
    Mitsopoulos, Efstathios
    Ginikopoulou, Eudoxia
    Economidou, Dominiki
    Zanos, Stavros
    Pateinakis, Panagiotis
    Minasidis, Elias
    Memmos, Dimitrios
    Thodis, Elias
    Vargemezis, Vassilis
    Tsakiris, Dimitrios
    AMERICAN JOURNAL OF NEPHROLOGY, 2012, 36 (03) : 238 - 244
  • [22] Effects of Lowering Dialysate Calcium Concentration on Bone Metabolic Markers in Hemodialysis Patients With Suppressed Serum Parathyroid Hormone: A Preliminary Study
    Niwa, Hiroki
    Fukasawa, Hirotaka
    Ishibuchi, Kento
    Kaneko, Mai
    Yasuda, Hideo
    Furuya, Ryuichi
    THERAPEUTIC APHERESIS AND DIALYSIS, 2018, 22 (05) : 503 - 508
  • [23] Long-Term Effects of Sglt2 Deletion on Bone and Mineral Metabolism in Mice
    Gerber, Claire
    Wang, Xueyan
    David, Valentin
    Quaggin, Susan E.
    Isakova, Tamara
    Martin, Aline
    JBMR PLUS, 2021, 5 (08)
  • [24] Low bone mineral density and fractures in long-term hemodialysis patients: A meta-analysis
    Jamal, Sophie A.
    Hayden, Jill A.
    Beyene, Joseph
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2007, 49 (05) : 674 - 681
  • [25] Effects of short- and long-term nicotine treatment on intracellular calcium and tyrosine hydroxylase gene expression
    Sabban, EL
    Gueorguiev, VD
    CHROMAFFIN CELL: TRNSMITTER BIOSYNTHESIS, STORAGE, RELEASE, ACTIONS, AND INFORMATICS, 2002, 971 : 39 - 44
  • [26] Short- and long-term effects of hemodialysis on platelet and monocyte activity markers of atherosclerosis in patients with end-stage renal disease
    Benck, Urs
    Stach, Ksenija
    Jung, Susanne
    Kraemer, Bernhard K.
    Kaelsch, Thorsten
    Kaelsch, Anna-Isabelle
    CARDIOLOGY JOURNAL, 2018, 25 (05) : 595 - 600
  • [27] Diminished Short- and Long-Term Antibody Response after SARS-CoV-2 Vaccination in Hemodialysis Patients
    Fueessl, Louise
    Lau, Tobias
    Lean, Isaac
    Hasmann, Sandra
    Riedl, Bernhard
    Arend, Florian M.
    Sorodoc-Otto, Johanna
    Soreth-Rieke, Daniela
    Toepfer, Marcell
    Rau, Simon
    Salihi-Halimi, Haxhrije
    Paal, Michael
    Beuthien, Wilke
    Thaller, Norbert
    Suttmann, Yana
    von Gersdorff, Gero
    Regenauer, Ron
    Von Bergwelt-Baildon, Anke
    Teupser, Daniel
    Bruegel, Mathias
    Fischereder, Michael
    Schoenermarck, Ulf
    VACCINES, 2022, 10 (04)
  • [28] Short- and long-term renal outcomes of immediate prophylactic hemodialysis after cardiovascular catheterizations in patients with severe renal insufficiency
    Hsieh, YC
    Ting, CT
    Liu, TJ
    Wang, CL
    Chen, YT
    Lee, WL
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2005, 101 (03) : 407 - 413
  • [29] Comparative analysis of short- and long-term outcomes in laparoscopic versus open surgery for colorectal cancer patients undergoing hemodialysis
    Hung, Hsin-Yuan
    Huang, Shu-Huan
    Tsai, Tzong-yun
    You, Jeng-Fu
    Hsieh, Pao-Shiu
    Lai, Cheng-Chou
    Tsai, Wen-Sy
    Tsai, Kun-Yu
    LANGENBECKS ARCHIVES OF SURGERY, 2024, 409 (01)
  • [30] Risk factors for erectile dysfunction in end-stage renal disease patients with short- or long-term hemodialysis therapy
    Nishida H.
    Yamagishi A.
    Sakurai T.
    Shibasaki T.
    Kawazoe H.
    Ichiyanagi O.
    Kato T.
    Nagaoka A.
    Tomita Y.
    Tsuchiya N.
    Renal Replacement Therapy, 2 (1)